Replies to post #30174 on Biotech Values

[DewDiligence]

ANDS closed at 6.98, off 18%. Investors did not buy the explanations for the CEO’s surprise departure. Nor should they, IMO.

The lupus connection is interesting (thanks for posting about it), but I doubt that’s a major factor in the CEO’s decision.